+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novo Nordisk A/S - logo

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Key products include diabetes care medications and devices. Novo Nordisk is also involved with hemostasis management, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries.

From
Anti-obesity Drugs Market - Product Thumbnail Image

Anti-obesity Drugs Market

  • Report
  • November 2023
  • 67 Pages
  • Global
From
Osteoporosis Treatment Market Report 2026 - Product Thumbnail Image

Osteoporosis Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Osteoporosis Drugs Market Report 2026 - Product Thumbnail Image

Osteoporosis Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Anti-Obesity Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Anti-Obesity Drugs Market - Global Forecast 2026-2032

  • Report
  • August 2026
  • 195 Pages
  • Global
From
From
From
From
From
From
Antiobesity Market Report 2026 - Product Thumbnail Image

Antiobesity Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Cardiovascular Collaboration and Licensing Deals 2016-2026 - Product Thumbnail Image

Cardiovascular Collaboration and Licensing Deals 2016-2026

  • Report
  • April 2026
  • 350 Pages
  • Global
From
Loading Indicator